US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS, SHANGHAI HENGRUI PHARMACEUTICAL on July 28 for "Pharmaceutical composition containing anti-IL-4R antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,174, issued on July 28, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD. (Shanghai).

"Pharmaceutical composition containing anti-IL-4R antibody and use thereof" was invented by Tingting Wu (Shanghai), Zhen Yan (Shanghai) and Xun Liu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a pharmaceutical composition containing an anti-IL-4R antibody and the use thereof. The pharmaceutical composition contains an anti-IL-4R antibody or an antigen-binding fragment thereof in a histidine-acetic acid buffer agent, a viscosity modifier, a surfactant, and a stabilizer....